Aardvark Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Aardvark Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Aardvark Therapeutics Inc.
Rating: 1.00025
Author: Trendlyne DVM scores

about

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective...

12.17 -0.43 (-3.41%)

37.84% Fall from 52W High

38,067

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Aardvark Therapeutics Inc. is on 16 Jul 2025 for the purpose of Aardvark Therapeutics Inc Annual General Meeting for 2025 See details